Late cytogenetic and molecular response to interferon-α (IFN-α) in chronic myelogenous leukemia (CML).

被引：0
|
作者：
Nosari, A
Perego, R
Pungolino, E
Cornacchini, G
Gargantini, L
Morra, E
机构：
[1] Niguarda Hosp, Dept Hematol, Milan, Italy
[2] Univ Milan, Inst Gen Pathol, Milan, Italy
[3] Univ Milan, CNR, Ctr Res Cellular Pathol, Milan, Italy
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2587
引用
收藏
页码：627A / 627A
页数：1
相关论文
共 50 条
  • [1] Expression of interferon-α (IFN-α) receptor 2c at diagnosis is associated with cytogenetic response in IFN-α-treated chronic myeloid leukemia
    Barthe, C
    Mahon, FX
    Gharbi, MJ
    Fabères, C
    Bilhou-Nabéra, C
    Hochhaus, A
    Reiffers, J
    Marit, G
    [J]. BLOOD, 2001, 97 (11) : 3568 - 3573
  • [2] Association of hla phenotype and response to interferon alfa (IFN) in patients with chronic myelogenous leukemia (CML).
    Cortes, J
    Kantarjian, H
    Talpaz, M
    [J]. BLOOD, 1995, 86 (10) : 1739 - 1739
  • [3] Sequential cladribine and interferon-alpha (IFN) in chronic myelogenous leukemia (CML).
    Saven, A
    Burian, C
    Kosty, M
    Mason, J
    Douer, D
    [J]. BLOOD, 1999, 94 (10) : 279B - 279B
  • [4] IFN-γ (interferon-gamma) Genotype Predict Cytogenetic and Molecular Response to Imatinib Therapy in Chronic Myeloid Leukemia
    Kim, Dong Hwan
    Kong, Jee Hyun
    Park, Silvia
    Jung, Chu Won
    Sriharsha, Lakshmi
    Xu, Wei
    Kamel-Reid, Suzanne
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lipton, Jeffrey H.
    [J]. BLOOD, 2009, 114 (22) : 857 - 857
  • [5] The adverse influence of pretransplant interferon-α (IFN-α) on transplant outcome after marrow transplantation for chronic phase chronic myelogenous leukemia increases with the duration of IFN-α exposure
    Beelen, DW
    Elmaagacli, AH
    Schaefer, UW
    [J]. BLOOD, 1999, 93 (05) : 1779 - 1780
  • [6] Extramedullary blast crisis in a patient with chronic myelogenous leukemia in complete cytogenetic and molecular remission on interferon-α therapy
    Beedassy, A
    Topolsky, D
    Styler, M
    Crilley, P
    [J]. LEUKEMIA RESEARCH, 2000, 24 (08) : 733 - 735
  • [7] Selection of molecular cytogenetic methodologies in diagnosis and monitoring of chronic myelogenous leukemia (CML).
    Dong, HY
    Sun, GX
    Weisberger, J
    Watts, C
    Zhang, WS
    Rainey, BJ
    Morgan, M
    Serrette, R
    [J]. BLOOD, 2003, 102 (11) : 322B - 323B
  • [8] Favourable survival of allogeneic stem cell transplantation after prior cytogenetic response to IFN in chronic myelogenous leukemia (CML).
    Reiter, A
    Maywald, O
    Metzgeroth, G
    Berger, U
    Hochhaus, A
    Pfirrmann, M
    Gnad, SU
    Kolb, HJ
    Gratwohl, A
    Bunjes, D
    Schaefer, UW
    Zander, AR
    Finke, J
    Arnold, R
    Fauser, AA
    Schwerdtfeger, R
    Sahakyan, L
    Hasford, J
    Hehlmann, R
    [J]. BLOOD, 2002, 100 (11) : 323B - 323B
  • [9] Cytogenetic and molecular response in CML patients on Interferon-α 2b (IFN-α 2b) therapy using conventional cytogenetics and FISH analysis
    Talwar, R
    Kucheria, K
    Chaudhry, VP
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 109 - 109
  • [10] INTERFERON ALFA-2C IN CHRONIC MYELOGENOUS LEUKEMIA (CML) - HEMATOLOGIC, CYTOGENETIC AND MOLECULAR-GENETIC RESPONSE OF PATIENTS WITH CHRONIC PHASE CML PREVIOUSLY RESISTANT TO THERAPY WITH INTERFERON-GAMMA
    HERRMANN, F
    JONAS, D
    HELFRICH, SG
    LINDEMANN, A
    SCHLEIERMACHER, E
    MERTELSMANN, R
    [J]. BLUT, 1990, 61 (04): : 226 - 231
12345